This is a routine annual meeting notice. No immediate action is required beyond reviewing the proxy materials and voting on the proposals. The outcome of the director elections and the shareholder proposal are the only items with potential, though minimal, market impact.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 12 $230.82entry
- T+1 · 8mo ago +1.88%α +2.48% · $235.16
- T+5 · 8mo ago +4.00%α +4.98% · $240.05
- T+20 · 7mo ago +10.96%α +8.99% · $256.12
- T+60 · 5mo ago +36.25%α +25.55% · $314.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable
Key Facts
- Filing is a DEFA14A (Definitive Additional Materials) for West Pharmaceutical Services, Inc.
- It is a proxy statement for the 2026 Annual Meeting.
- The meeting will be held virtually on May 4, 2026.
- Proposals include the election of 11 directors, an advisory vote on executive compensation, ratification of the independent auditor, and a shareholder proposal on an independent board chair.
Financial Impact
No financial impact from this filing.
Risk Factors
- The shareholder proposal for an independent board chair could signal governance concerns if it receives significant support, though it is opposed by management.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-026779 |
| Document: 0001104659-26-026779-index-headers.html | 0001104659-26-026779 |
| Document: 0001104659-26-026779-index.html | 0001104659-26-026779 |
| Document: 0001104659-26-026779.txt | 0001104659-26-026779 |
Track record
17 reports on WST
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.33% at T+60 after the Apr 23, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $392.48 Now $417.80 +6.45% settles Feb 3
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $416.67 Now $417.80 +0.27% settles Jan 27
- Oct 26, 202621d ago 8-K Neutral 4/10 Entry $398.29 Now $417.80 +4.90% settles Jan 25
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $394.73 Now $417.80 +5.84% settles Jan 22
- Jul 23, 202616w ago 8-K Bullish 7/10 No price data
- Jul 23, 202616w ago Press Release Bullish 7/10 Entry $355.48 to $383.02 Now $417.80 +17.53% ▲ +7.75% +3.19% vs SPY
- Jul 7, 202618w ago Press Release Neutral 1/10 Entry $356.08 to $370.76 Now $417.80 +17.33% ▲ +4.12% +2.13% vs SPY
- May 11, 202627w ago 8-K Bearish 7/10 Entry $311.82 to $348.06 Now $417.80 −33.99% ▼ −11.62% −7.51% vs SPY
- Apr 27, 202629w ago Insider Cluster Neutral 2/10 Entry $300.93 to $358.41 Now $417.80 +38.83% ▲ +19.10% +14.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers